News
DCGI Approves Market Authorisation to COVID-19 Vaccine Covovax as Heterologous Booster ... - Latest Tweet by PTI News
The latest Tweet by PTI News states, 'DCGI approves market authorisation to COVID-19 vaccine Covovax as heterologous booster dose for adults administered two doses of Covishield or Covaxin: Official sources'
DCGI approves market authorisation to COVID-19 vaccine Covovax as heterologous booster dose for adults administered two doses of Covishield or Covaxin: Official sources— Press Trust of India (@PTI_News) January 16, 2023
(The above story first appeared on LatestLY on Jan 16, 2023 11:14 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
